Receipt of Guideline-Recommended Surveillance in a Population-Based Cohort of Prostate Cancer Patients Undergoing Active Surveillance
Authors:
- 1 July 2021
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 110 (3) , 712-715
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- Agency for Healthcare Research and Quality
- Patient-Centered Outcomes Research Institute
This publication has 12 references indexed in Scilit:
- Active Surveillance of Grade Group 1 Prostate Cancer: Long-term Outcomes from a Large Prospective CohortEuropean Urology, 2020
- Risk of Becoming Lost to Follow-up During Active Surveillance for Prostate CancerEuropean Urology, 2018
- Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care OptionsJournal of Urology, 2018
- Variation in Guideline Concordant Active Surveillance Followup in Diverse Urology PracticesJournal of Urology, 2017
- 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate CancerNew England Journal of Medicine, 2016
- How Active is Active Surveillance? Intensity of Followup during Active Surveillance for Prostate Cancer in the United StatesJournal of Urology, 2016
- Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline EndorsementJournal of Clinical Oncology, 2016
- Design of the North Carolina Prostate Cancer Comparative Effectiveness and Survivorship Study (NC ProCESS)Journal of Comparative Effectiveness Research, 2015
- Clinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort With Localized Prostate CancerJournal of Clinical Oncology, 2010
- The Memorial Anxiety Scale for Prostate CancerCancer, 2003